JP2006526608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006526608A5 JP2006526608A5 JP2006508422A JP2006508422A JP2006526608A5 JP 2006526608 A5 JP2006526608 A5 JP 2006526608A5 JP 2006508422 A JP2006508422 A JP 2006508422A JP 2006508422 A JP2006508422 A JP 2006508422A JP 2006526608 A5 JP2006526608 A5 JP 2006526608A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- formula
- methoxy
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 2
- 125000006582 (C5-C6) heterocycloalkyl group Chemical group 0.000 claims description 2
- BVCRERJDOOBZOH-UHFFFAOYSA-N bicyclo[2.2.1]heptanyl Chemical group C1C[C+]2CC[C-]1C2 BVCRERJDOOBZOH-UHFFFAOYSA-N 0.000 claims description 2
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 2
- 125000005508 decahydronaphthalenyl group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000003566 oxetanyl group Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010189 synthetic method Methods 0.000 description 2
- 0 COc(cc12)ccc1[o]c(C(Nc1nnn[n]1)=O)c2O* Chemical compound COc(cc12)ccc1[o]c(C(Nc1nnn[n]1)=O)c2O* 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47625103P | 2003-06-05 | 2003-06-05 | |
| PCT/IB2004/001788 WO2004108709A1 (en) | 2003-06-05 | 2004-05-24 | Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006526608A JP2006526608A (ja) | 2006-11-24 |
| JP2006526608A5 true JP2006526608A5 (enExample) | 2007-09-06 |
Family
ID=33511768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006508422A Abandoned JP2006526608A (ja) | 2003-06-05 | 2004-05-24 | Ｐｉ３ｋ活性を有する治療薬としてのテトラゾールベンゾフランカルボキシアミド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050020631A1 (enExample) |
| EP (1) | EP1644364A1 (enExample) |
| JP (1) | JP2006526608A (enExample) |
| BR (1) | BRPI0411098A (enExample) |
| CA (1) | CA2527934A1 (enExample) |
| MX (1) | MXPA05012894A (enExample) |
| WO (1) | WO2004108709A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667300B2 (en) | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| US8906894B1 (en) * | 2000-07-27 | 2014-12-09 | Thomas N. Thomas | Methods for preventing and treating thrombotic disorders |
| US20050043239A1 (en) * | 2003-08-14 | 2005-02-24 | Jason Douangpanya | Methods of inhibiting immune responses stimulated by an endogenous factor |
| US20050054614A1 (en) * | 2003-08-14 | 2005-03-10 | Diacovo Thomas G. | Methods of inhibiting leukocyte accumulation |
| FR2862646B1 (fr) * | 2003-11-20 | 2006-02-24 | Merck Sante Sas | Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
| BRPI0509580A (pt) * | 2004-03-30 | 2007-11-27 | Pfizer Prod Inc | combinações de inibidores de transdução de sinal |
| LT2612862T (lt) | 2004-05-13 | 2017-01-25 | Icos Corporation | Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai |
| WO2005117889A1 (en) * | 2004-05-25 | 2005-12-15 | Icos Corporation | Methods for treating and/or preventing aberrant proliferation of hematopoietic |
| US20080287469A1 (en) * | 2005-02-17 | 2008-11-20 | Diacovo Thomas G | Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation |
| US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| KR20170060179A (ko) | 2008-11-13 | 2017-05-31 | 길리아드 칼리스토가 엘엘씨 | 혈액 종양에 대한 요법 |
| AU2010229968A1 (en) | 2009-03-24 | 2011-10-13 | Gilead Calistoga Llc | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| JP2012524126A (ja) | 2009-04-20 | 2012-10-11 | ギリアド カリストガ リミテッド ライアビリティ カンパニー | 固形腫瘍の治療方法 |
| CA2768843A1 (en) | 2009-07-21 | 2011-01-27 | Gilead Calistoga Llc | Treatment of liver disorders with pi3k inhibitors |
| EP2492269A4 (en) | 2009-10-19 | 2013-08-07 | Taisho Pharmaceutical Co Ltd | aminothiazole |
| PL223225B1 (pl) * | 2012-02-21 | 2016-10-31 | Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk | Halogenopochodne benzo[b]furanów, ewentualnie w postaci farmaceutycznie dopuszczalnej soli oraz zastosowanie halogenopochodnych benzo[b]furanów |
| ES2848273T3 (es) | 2012-03-05 | 2021-08-06 | Gilead Calistoga Llc | Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona |
| JP2017500319A (ja) | 2013-12-20 | 2017-01-05 | ギリアード カリストガ エルエルシー | （ｓ）−２−（１−（９ｈ−プリン−６−イルアミノ）プロピル）−５−フルオロ−３−フェニルキナゾリン−４（３ｈ）−オンの塩酸塩の多形形態 |
| EP3083630B1 (en) | 2013-12-20 | 2019-08-21 | Gilead Calistoga LLC | Process methods for phosphatidylinositol 3-kinase inhibitors |
| US11021467B2 (en) | 2014-06-13 | 2021-06-01 | Gilead Sciences, Inc. | Phosphatidylinositol 3-kinase inhibitors |
| US11351156B2 (en) | 2017-10-13 | 2022-06-07 | Inserm | Combination treatment of pancreatic cancer |
| WO2019101871A1 (en) | 2017-11-23 | 2019-05-31 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | A new marker for predicting the sensitivity to pi3k inhibitors |
| MX2023014819A (es) * | 2021-06-14 | 2024-03-21 | Scorpion Therapeutics Inc | Derivados de la urea que pueden ser utilizados para tratar el cancer. |
| CN117813293A (zh) * | 2021-06-14 | 2024-04-02 | 蝎子疗法股份有限公司 | 可用于治疗癌症的脲衍生物 |
| WO2025087879A2 (en) | 2023-10-23 | 2025-05-01 | Institut National de la Santé et de la Recherche Médicale | Suppressing the pi3kgamma/akt signalling pathway for the treatment of acute myeloid leukemia |
| TW202600543A (zh) * | 2024-03-11 | 2026-01-01 | 大陸商長春金賽藥業有限責任公司 | ＰＩ３Ｋα抑制劑化合物、藥物組合物及其用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3954748A (en) * | 1968-07-29 | 1976-05-04 | Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France | 3-Alkoxy-thianapthene-2-carboxamides |
| US4703053A (en) * | 1985-10-28 | 1987-10-27 | Warner-Lambert Company | Benzothiophenes and benzofurans and antiallergic use thereof |
| IE58555B1 (en) * | 1984-12-10 | 1993-10-06 | Warner Almbert Company | Novel benzothiophenes and benzofurans having antiallergy activity |
| US4800211A (en) * | 1986-08-18 | 1989-01-24 | Merck & Co., Inc. | 5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors |
| US4767776A (en) * | 1987-02-20 | 1988-08-30 | Warner-Lambert Company | N-1H-tetrazol-5-yl-2-naphthalene carboxamides and their use as antiallergy and antiinflammatory agents |
| US4764525A (en) * | 1987-02-25 | 1988-08-16 | Warner-Lambert Company | N-1H-tetrazol-5-ylbenzamides having use as antiallergy and antiinflammatory agents |
| US4931459A (en) * | 1987-07-14 | 1990-06-05 | Warner-Lambert Company | Method for treating acute respirator distress syndrome |
| US4910317A (en) * | 1987-07-14 | 1990-03-20 | Warner-Lambert Company | Benzofurans and benzothiophenes having antiallergic activity and method of use thereof |
| AU8641991A (en) * | 1990-09-10 | 1992-03-30 | Rhone-Poulenc Rorer International (Holdings) Inc. | Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| US5208253A (en) * | 1992-02-24 | 1993-05-04 | Warner-Lambert Company | 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo(b) thiophene-2-carboxamides as inhibitors of cell adhesion |
| US5426113A (en) * | 1994-04-08 | 1995-06-20 | Warner-Lambert Company | Method of preventing ulcer formation caused by nonsteroidal antiinflammatory drugs employing tetrazol-benzothiophene carboxamide compounds |
| HRP950288A2 (en) * | 1994-05-31 | 1997-08-31 | Bayer Ag | Oxalylamino-benzofuran- and benzothienyl-derivatives |
| US5731317A (en) * | 1995-03-10 | 1998-03-24 | Merck & Co., Inc. | Bridged piperidines promote release of growth hormone |
| WO1997009056A1 (fr) * | 1995-09-07 | 1997-03-13 | L'oreal | Extrait d'iridacees et compositions le contenant |
| DE19911165B4 (de) * | 1999-03-12 | 2008-03-13 | Bayer Cropscience Ag | Entlaubungsmittel |
| US6444613B1 (en) * | 1999-03-12 | 2002-09-03 | Hoechst Schering Agrevo Gmbh | Defoliant |
| ATE363471T1 (de) * | 2000-01-24 | 2007-06-15 | Astrazeneca Ab | Durch einen morpholinrest substituierte therapeutische verbindungen |
-
2004
- 2004-05-24 WO PCT/IB2004/001788 patent/WO2004108709A1/en not_active Ceased
- 2004-05-24 JP JP2006508422A patent/JP2006526608A/ja not_active Abandoned
- 2004-05-24 BR BRPI0411098-6A patent/BRPI0411098A/pt not_active IP Right Cessation
- 2004-05-24 CA CA002527934A patent/CA2527934A1/en not_active Abandoned
- 2004-05-24 EP EP04734569A patent/EP1644364A1/en not_active Withdrawn
- 2004-05-24 MX MXPA05012894A patent/MXPA05012894A/es not_active Application Discontinuation
- 2004-06-03 US US10/860,527 patent/US20050020631A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532135A5 (enExample) | ||
| JP2005536519A5 (enExample) | ||
| JP2004521124A5 (enExample) | ||
| JP2012510502A5 (enExample) | ||
| JP2004083852A5 (enExample) | ||
| JP2007511546A5 (enExample) | ||
| JP2007518682A5 (enExample) | ||
| AR028683A1 (es) | Derivados de 1,3,8-triaza-espiro[4.5]decan-4-ona | |
| JP2006522035A5 (enExample) | ||
| JP2011514884A5 (enExample) | ||
| JP2007510619A5 (enExample) | ||
| JP2007508359A5 (enExample) | ||
| JP2005538950A5 (enExample) | ||
| JP2011137006A5 (enExample) | ||
| JP2002502874A5 (enExample) | ||
| JP2004530641A5 (enExample) | ||
| JP2012532848A5 (enExample) | ||
| JP2005289914A5 (enExample) | ||
| JP2013509392A5 (enExample) | ||
| JP2003261873A5 (enExample) | ||
| JP2004527536A5 (enExample) | ||
| JP2004529953A5 (enExample) | ||
| JP2010535706A5 (enExample) | ||
| RU2007132260A (ru) | Синтез арилпирролидонов | |
| RU2004117595A (ru) | Производные пиридина в качестве лигандов рецептора nmda |